Naval Daver, MD

No bio available.

Financial relationships

  • Attribution:
    Other
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Trillium
    Date added:
    04/12/2023
    Date updated:
    04/12/2023
  • Attribution:
    Other
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Hanmi
    Date added:
    04/12/2023
    Date updated:
    04/12/2023
  • Attribution:
    Other
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Trovagene
    Date added:
    04/12/2023
    Date updated:
    04/12/2023
  • Attribution:
    Other
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    FATE Therapeutics
    Date added:
    04/12/2023
    Date updated:
    04/12/2023
  • Attribution:
    Other
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Novimmune
    Date added:
    04/12/2023
    Date updated:
    04/12/2023
  • Attribution:
    Other
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Glycomimmetics
    Date added:
    04/12/2023
    Date updated:
    04/12/2023
  • Attribution:
    Other
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    KITE
    Date added:
    04/12/2023
    Date updated:
    04/12/2023
  • Attribution:
    Self
    Type of financial relationship:
    Other
    Ineligible company:
    Daiichi-Sankyo
    Date added:
    04/12/2023
    Date updated:
    04/12/2023
  • Attribution:
    Self
    Type of financial relationship:
    Other
    Ineligible company:
    Bristol-Meyers Squibb
    Date added:
    04/12/2023
    Date updated:
    04/12/2023
  • Attribution:
    Self
    Type of financial relationship:
    Other
    Ineligible company:
    Pfizer
    Date added:
    04/12/2023
    Date updated:
    04/12/2023

Pages

Return to Seattle Cellular Therapy Summit: Patient-Centered Approach to Improve Outcomes